ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Potassium Iodide → 7-(4-(4-(1,2-benzisothiazol-3-yl) piperazin-1-yl)butyryl)-2,3-dihydrothieno[3,2-f][1,4]thiazepin-5(4H)-one oxalate

HRID 1734038
印刷

反応式

HRID 1734038 の反応式
Cl.[S:2]1[C:6]2[CH:7]=[CH:8][CH:9]=[CH:10][C:5]=2[C:4]([N:11]2[CH2:16][CH2:15][NH:14][CH2:13][CH2:12]2)=[N:3]1.Cl[CH2:18][CH2:19][CH2:20][C:21]([C:23]1[S:32][C:31]2[S:30][CH2:29][CH2:28][NH:27][C:26](=[O:33])[C:25]=2[CH:24]=1)=[O:22].[C:34](=[O:37])([O-:36])[O-].[K+].[K+].[I-].[K+].CN(C)C=[O:45]>C1(C)C=CC=CC=1.O>[C:26]([OH:33])(=[O:45])[C:34]([OH:36])=[O:37].[S:2]1[C:6]2[CH:7]=[CH:8][CH:9]=[CH:10][C:5]=2[C:4]([N:11]2[CH2:12][CH2:13][N:14]([CH2:18][CH2:19][CH2:20][C:21]([C:23]3[S:32][C:31]4[S:30][CH2:29][CH2:28][NH:27][C:26](=[O:33])[C:25]=4[CH:24]=3)=[O:22])[CH2:15][CH2:16]2)=[N:3]1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 4875Potassium IodideHCID 6228DimethylformamideHCID 11430Potassium CarbonateHCID 115217113-(1-Piperazinyl)-1,2-benzisothiazole monohydrochlorideHCID 214720567-(4-chlorobutyryl)-2,3-dihydrothieno[3,2-f][1,4]thiazepin-5(4H)-one

生成物 1

HCID 67744150
7-(4-(4-(1,2-benzisothiazol-3-yl) piperazin-1-yl)butyryl)-2,3-dihydrothieno[3,2-f][1,4]thiazepin-5(4H)-one oxalate

試薬・触媒・溶媒 2

HCID 962Water溶媒HCID 1140Toluene溶媒

反応条件

温度
100 °C

実験手順

The mixture of 1.0 g of 4-(1,2-benzisothiazol-3-yl)piperazine hydrochloride, 1.5 g of 7-(4-chlorobutyryl)-2,3-dihydrothieno[3,2-f][1,4]thiazepin-5(4H)-one, 2.5 g of potassium carbonate and 0.8 g of potassium iodide in 25 ml of N,N-dimethylformamide and 25 ml of toluene was stirred at 100° C. for 24 hours. After the mixture was cooled in a water bath, water was added thereto and the mixture was extracted with ethyl acetate. The organic layer was washed with saline solution, dried over magnesium sulfate and concentrated. The residue was purified by column chromatography on a silica gel, dissolved in isopropyl alcohol and oxalic acid was added thereto to make oxalate. The resulting crystals were recrystallized from isopropyl alcohol to give 0.12 g of 7-(4-(4-(1,2-benzisothiazol-3-yl) piperazin-1-yl)butyryl)-2,3-dihydrothieno[3,2-f][1,4]thiazepin-5(4H)-one oxalate 1/2 hydrate as white crystals, m.p. 118°-120° C.

後処理

  1. temperatureAfter the mixture was cooled in a water bath
  2. extractionthe mixture was extracted with ethyl acetate
  3. washThe organic layer was washed with saline solution
  4. dry with materialdried over magnesium sulfate
  5. concentrationconcentrated
  6. customThe residue was purified by column chromatography on a silica gel
  7. dissolutiondissolved in isopropyl alcohol
  8. additionoxalic acid was added
  9. customThe resulting crystals were recrystallized from isopropyl alcohol

出典と根拠

ORDレコード
ord-2dffb9b2d6bf4db5858884ef2c802975
出典データセット
uspto-grants-1996_07
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US05532240

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート